Scientists uncover two-pronged strategy to overcome glioblastoma's resistance to immunotherapy

Scientists found a combination treatment to overcome glioblastoma's resistance to immunotherapy.

The study, published in Neuro-Oncology, shows reprogramming myeloid cells and boosting T cells can shrink tumors.